Clinical Relevance of TP53 Mutation and Its Characteristics in Breast Cancer with Long-Term Follow-Up Date
Our findings establish that <i>TP53</i> mutations are linked to poorer oncologic outcomes in breast cancer across all subtypes. Yet, within the <i>TP53</i>-mutated group, the specific characteristics of <i>TP53</i> mutations do not influence oncologic outcomes.
Authors
- Sung Gwe Ahn (ORCID: https://orcid.org/0000-0002-8778-9686)
- Yoonwon Kook (ORCID: https://orcid.org/0000-0002-0756-738X)
- Joon Jeong (ORCID: https://orcid.org/0000-0003-0397-0005)
- Soong June Bae (ORCID: https://orcid.org/0000-0002-0012-9694)
- Seung Ho Baek (ORCID: https://orcid.org/0000-0003-3681-6506)
- Min Ji Lee
- Seung Hyun Hwang (ORCID: https://orcid.org/0000-0002-2101-5944)
Institutions
- Yonsei University (KR)
- Yang Hospital (KR)
- Gangnam Severance Hospital (KR)
Publication Details
- Journal
- Cancers
- Published
- 2024-11-21
- DOI
- https://doi.org/10.3390/cancers16233899
- Citations
- 12
- Primary Topic
- Cancer Genomics and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 3.42